Business Context and Reporting Period
This Form 8-K Current Report is filed by Klotho Neurosciences, Inc. (not Greenland Mines Ltd as indicated in metadata) for the reporting period ending June 9, 2025. The registrant is an emerging growth company incorporated in Delaware, with its principal executive offices in Omaha, NE. The filing discloses material definitive agreements and unregistered sales of equity securities.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial figure disclosed is:
- Capital Raised: $500,000 from the sale of Series B Preferred stock.
Material Changes and Events
Two significant corporate actions were reported:
- Termination of Acquisition Agreement: On June 9, 2025, the Company mutually agreed with Skybell Technologies, Inc. to terminate the March 26, 2025 Share Exchange Agreement regarding the acquisition of SB Security Holdings, LLC. A formal Termination and Release Agreement was executed on June 13, 2025. Neither party will incur liability as a result of this termination.
- Unregistered Equity Sale: On June 9, 2025, the Company entered into a Stock Purchase Agreement to sell Series B Preferred stock for $500,000. These shares are convertible into Common Stock once a registration statement is declared effective by the SEC. The sale relied on Section 4(2) of the Securities Act of 1933.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosures regarding the equity sale. The Series B Preferred stock includes a restrictive legend and stop-transfer instructions, and the sale was conducted without underwriters or commissions.
Investor Verification Checklist
- Verify the status of the terminated acquisition of SB Security Holdings, LLC and confirm no hidden liabilities exist despite the release agreement.
- Confirm the identity and accreditation status of the purchaser of the $500,000 Series B Preferred stock.
- Monitor the filing status of the registration statement required to make the Series B Preferred stock convertible into Common Stock.
- Review the full text of the Termination and Release Agreement (Exhibit 4.1) for any non-public terms.